companydata.dkcompanydata.dk

DEEPSEAPHARMA ApS: Financial statements 2025

CVR: 32561365

Source: annual report 2025, Danish Business Authority

01/10/202430/09/2025

DEEPSEAPHARMA ApS (CVR 32561365) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 4,910,748 and a net result of DKK 3,145,783 compared with DKK 2,246,538 the year before. That is an increase of 25.6% compared with the year before. Equity in the 2025 report amounted to DKK 7,011,081. The solvency ratio was 71.6%. The company had 1 employee in the financial year.

Gross Profit
DKK 4,910,748
Profit/Loss
DKK 3,145,783
Equity
DKK 7,011,081
Total Assets
DKK 9,795,630
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-4.9 mio.3.1 mio.7 mio.1
2024-3.9 mio.2.2 mio.4.7 mio.1
2023-4.4 mio.2.2 mio.3.2 mio.1
2022-2.6 mio.605 t.1.6 mio.2
2021-3.1 mio.1.1 mio.1.8 mio.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is DEEPSEAPHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

DEEPSEAPHARMA ApS: The 2024 annual report is outMar 31, 2025

DEEPSEAPHARMA ApS has published its annual report for 2024. Gross profit came to DKK 3,908,735, and the net result was DKK 2,246,538.

About DEEPSEAPHARMA ApS

DEEPSEAPHARMA ApS is a Danish company of the type Anpartsselskab based in Hinnerup, founded in 2009. The company is registered under the industry Engroshandel med fisk og fiskeprodukter. The management consists of Kristian Rousku Andersen. The company is owned by DISOP HOLDING ApS. The company has 6 employees (2018). In 2025, the company reported a gross profit of DKK 4,910,748 and a net result of DKK 3,145,783 compared with DKK 2,246,538 the year before. Equity in the 2025 report amounted to DKK 7,011,081.

Source: annual report 2025, Danish Business Authority